Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 748-752 Year: 2001
VNTR polymorphism NOS3 gene among chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Angiotensin-converting-enzyme gene polymorphism and susceptibility to chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 195s Year: 2002
Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients Source: Eur Respir J 2004; 24: Suppl. 48, 315s Year: 2004
Association of -308G/A polymorphism of TNF gene with the activity of proteases and antiproteases in sputum in COPD patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
Genetic polymorphisms in MMP9 and TIMP2 genes and risk of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009
Association of the 3A/4A (134delA) and Lys198Asn polymorphisms of the endothelin-1 gene with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Differences in serum levels of inflammatory markers, proteases and antiproteases in COPD patients with and without emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Genetic susceptibility to chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=84 Year: 2006
Polymorphism of GSTP1 and EPHX1 genes in smokers and patients with I and II stages of chronic obstructive pulmonary disease Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012
Association of NOS3 gene polymorphisms with the activity of proteases and antiproteases in COPD patients Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009